Osborne Partners Capital Management’s Amgen AMGN Stock Holding History

Osborne Partners Capital Management’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.26M	Hold	12,110	–	–	0.23%	104
2025 Q4	$3.96M	Hold	12,110	–	–	0.2%	107
2025 Q3	$3.42M	Hold	12,110	–	–	0.17%	112
2025 Q2	$3.38M	Sell	12,110 -365	-3%	-$103K	0.18%	114
2025 Q1	$3.89M	Hold	12,475	–	–	0.22%	107
2024 Q4	$3.25M	Buy	12,475 +50	+0.4%	+$14.8K	0.19%	110
2024 Q3	$4M	Buy	12,425 +60	+0.5%	+$19.6K	0.23%	106
2024 Q2	$3.86M	Hold	12,365	–	–	0.23%	107
2024 Q1	$3.52M	Hold	12,365	–	–	0.22%	108
2023 Q4	$3.56M	Hold	12,365	–	–	0.23%	106
2023 Q3	$3.32M	Sell	12,365 -200	-2%	-$49.9K	0.25%	101
2023 Q2	$2.79M	Hold	12,565	–	–	0.2%	107
2023 Q1	$3.04M	Hold	12,565	–	–	0.22%	106
2022 Q4	$3.3M	Hold	12,565	–	–	0.26%	99
2022 Q3	$2.83M	Hold	12,565	–	–	0.24%	106
2022 Q2	$3.06M	Buy	+12,565	New	+$3.08M	0.23%	103
2021 Q1	–	Sell	-12,425	Closed	-$2.86M	–	194
2020 Q4	$2.86M	Buy	+12,425	New	+$2.86M	0.35%	80
2019 Q4	–	Sell	-4,125	Closed	-$798K	–	155
2019 Q3	$798K	Buy	4,125 +125	+3%	+$24K	0.16%	92
2019 Q2	$737K	Sell	4,000 -200	-5%	-$35.8K	0.14%	98
2019 Q1	$798K	Sell	4,200 -12,679	-75%	-$2.42M	0.16%	90
2018 Q4	$3.29M	Hold	16,879	–	–	0.49%	67
2018 Q3	$3.5M	Sell	16,879 -106	-0.6%	-$20.9K	0.45%	76
2018 Q2	$3.13M	Buy	16,985 +56	+0.3%	+$9.91K	0.43%	79
2018 Q1	$2.89M	Sell	16,929 -94	-0.6%	-$17.3K	0.4%	78
2017 Q4	$2.96M	Hold	17,023	–	–	0.39%	78
2017 Q3	$3.17M	Hold	17,023	–	–	0.43%	78
2017 Q2	$2.93M	Buy	17,023 +91	+0.5%	+$14.8K	0.42%	77
2017 Q1	$2.78M	Buy	16,932 +109	+0.6%	+$18.1K	0.4%	81
2016 Q4	$2.46M	Hold	16,823	–	–	0.36%	83
2016 Q3	$2.81M	Sell	16,823 -225	-1%	-$38K	0.42%	74
2016 Q2	$2.59M	Hold	17,048	–	–	0.39%	75
2016 Q1	$2.56M	Hold	17,048	–	–	0.38%	77
2015 Q4	$2.77M	Sell	17,048 -150	-0.9%	-$23.6K	0.4%	76
2015 Q3	$2.38M	Hold	17,198	–	–	0.35%	77
2015 Q2	$2.64M	Hold	17,198	–	–	0.35%	79
2015 Q1	$2.75M	Hold	17,198	–	–	0.36%	77
2014 Q4	$2.74M	Hold	17,198	–	–	0.33%	74
2014 Q3	$2.42M	Sell	17,198 -50	-0.3%	-$6.53K	0.31%	76
2014 Q2	$2.04M	Sell	17,248 -600	-3%	-$69.5K	0.26%	83
2014 Q1	$2.2M	Sell	17,848 -205	-1%	-$24.9K	0.29%	81
2013 Q4	$2.06M	Buy	18,053 +600	+3%	+$68.3K	0.27%	82
2013 Q3	$1.95M	Sell	17,453 -200	-1%	-$21.7K	0.27%	84
2013 Q2	$1.74M	Buy	+17,653	New	+$1.83M	0.25%	86

Other funds holding AMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Osborne Partners Capital Management's AMGN Position: Q1 2026 in Review

Osborne Partners Capital Management held its Amgen (AMGN) position steady in Q1 2026 at 12,110 shares worth $4.26M. The position accounts for 0.23% of the portfolio, ranked #104.

Osborne Partners Capital Management first reported a position in AMGN in Q2 2013 and has held it in 43 quarters since. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

Osborne Partners Capital Management held 12,110 shares of Amgen worth $4.26M as of Q1 2026.
Osborne Partners Capital Management left its Amgen share count unchanged in Q1 2026.
Amgen made up 0.23% of Osborne Partners Capital Management's portfolio in Q1 2026, its #104 holding.
Osborne Partners Capital Management first reported a position in Amgen in Q2 2013 and has held it in 43 quarters since.
3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Osborne Partners Capital Management's 13F filing for Q1 2026, filed 27 Apr 2026.